166
landing page
Upcoming Events | Africa
Upcoming events that will mobilize the Milken Institute’s Africa stakeholders and the Africa Leaders
Business Council include the following:
+ Read More
landing page
Featured Past Events | Africa
landing page
Africa | MI International
landing page
Distance as an Obstacle to Clinical Trial Access: Who Is Affected and Why It Matters
The interactive map below shows the distance from any county in the United States to the nearest cou
nty containing a Phase 2 or 3 clinical trial that was run between 2017 and 2023 based on the data available on
+ Read More
landing page
Asia Summit 2022 Livestream
Looking for a session? Scroll down this page to find it.
landing page
Power of Ideas - Asia Summit 2022
About the 2022 Power of Ideas Asia Summit Collection
In this collection of Power of Ideas ess
ays, thought leaders share their perspec
+ Read More
landing page
Asia Summit 2022
landing page
FasterCures and COVID-19
Ending the Crisis
The goal of FasterCures is to understand how industry and government are working
to end the COVID-19 crisis. To help us in this mission, we have created Four Pillars., FasterCures: COVID-19 Action Recommendations
Learn More About the Recommendations
+ Read More
person
Edward McGee
Edward McGee is the interim CEO and chief financial officer of Grayscale Investments, overseeing
daily financial activities and identifying growth opportunities for the company.
+ Read More
staff
Tanisha London, PhD
Tanisha London, PhD, is a senior associate with the Milken Institute Science Philanthropy Acceler
ator for Research and Collaboration (SPARC) team.
+ Read More
staff
Danielle Graham
Danielle Graham is a senior associate at MI Philanthropy working to advance the learning agenda a
nd giving practices of corporate philanthropy leaders and other philanthropic actors.
+ Read More
staff
Taylor Evans, PhD
Taylor Evans, PhD, is a senior associate at the Milken Institute Science Philanthropy Accelerator
for Research and Collaboration (SPARC). Her expertise lies in biomedical research, molecular genetics, rare diseases, and computational biology tools.
+ Read More